183 related articles for article (PubMed ID: 2590267)
41. Comparative pharmacokinetics of morning and evening doses of once-a-day theophylline capsules.
Harrison LI; Kehe CR; Ekholm BP; Chang SF; Lavoie KA; Kisicki JC
J Pharm Sci; 1994 Aug; 83(8):1171-4. PubMed ID: 7983603
[TBL] [Abstract][Full Text] [Related]
42. Once-daily dosing of a new ultrasustained-release theophylline preparation.
Van den Brande P; Nys J; Tjandramaga TB; Verhelst F; Demedts M
Respiration; 1987; 52(2):144-53. PubMed ID: 3671893
[TBL] [Abstract][Full Text] [Related]
43. Treatment of asthma by a controlled-release theophylline tablet formulation: a review of the North American experience with nocturnal dosing.
Goldenheim PD; Conrad EA; Schein LK
Chronobiol Int; 1987; 4(3):397-408. PubMed ID: 3315269
[TBL] [Abstract][Full Text] [Related]
44. A study on the chronopharmacokinetics of theophylline in rabbits.
Kumar A; Chakrabarti A; Garg SK
Indian J Physiol Pharmacol; 1991 Jul; 35(3):187-90. PubMed ID: 1791059
[TBL] [Abstract][Full Text] [Related]
45. Review of the North American experience with evening administration of Uniphyl tablets, a once-daily theophylline preparation, in the treatment of nocturnal asthma.
Arkinstall WW
Am J Med; 1988 Jul; 85(1B):60-3. PubMed ID: 3400688
[TBL] [Abstract][Full Text] [Related]
46. [Chronotherapy concept and the pharmacokinetic validation of a theophylline retard preparation for once-nightly administration (Euphylong)].
Steinijans VW; Sauter R; Böhm A; Dietrich R; Benedikt G
Pneumologie; 1991 Nov; 45 Suppl 4():827-33. PubMed ID: 1812475
[TBL] [Abstract][Full Text] [Related]
47. Theophylline steady-state pharmacokinetics: recent concepts and their application in chronotherapy of reactive airway diseases.
Steinijans VW; Trautmann H; Johnson E; Beier W
Chronobiol Int; 1987; 4(3):331-47. PubMed ID: 3315264
[TBL] [Abstract][Full Text] [Related]
48. Temporal variation in the disposition of theophylline and its metabolites.
St-Pierre MV; Spino M; Isles AF; Tesoro A; MacLeod SM
Clin Pharmacol Ther; 1985 Jul; 38(1):89-95. PubMed ID: 4039998
[TBL] [Abstract][Full Text] [Related]
49. Pharmacokinetics of intravenous theophylline in pregnant patients at term.
Romero R; Kadar N; Gonzales Govea F; Hobbins JC
Am J Perinatol; 1983 Oct; 1(1):31-5. PubMed ID: 6680648
[TBL] [Abstract][Full Text] [Related]
50. [Chronopharmacokinetics of digoxin in compensated cardiac patients].
Kopecká J; Janků I; Pidrman V; Martínková J
Vnitr Lek; 1992 Jun; 38(6):566-72. PubMed ID: 1529562
[TBL] [Abstract][Full Text] [Related]
51. Comparison of morning and evening dosing with a 24-hour sustained-release theophylline, Uniphyl, for nocturnal asthma.
Busse WW; Bush RK
Am J Med; 1985 Dec; 79(6A):62-6. PubMed ID: 4083302
[TBL] [Abstract][Full Text] [Related]
52. [The effect of ranitidine on theophylline pharmacokinetics in patients with obstructive lung disease].
Paranos S; Despotović N; Vidanović M; Bojović I; Milovanović M; Dmitrović V
Plucne Bolesti; 1991; 43(1-2):89-93. PubMed ID: 1766997
[TBL] [Abstract][Full Text] [Related]
53. Chronobiology and asthma. II. Body-time-dependent differences in the kinetics and effects of bronchodilator medications.
Smolensky MH; McGovern JP; Scott PH; Reinberg A
J Asthma; 1987; 24(2):91-134. PubMed ID: 2975286
[TBL] [Abstract][Full Text] [Related]
54. Time-dependent absorption of theophylline in man.
Watanabe H; Nakano S; Nagai K; Ogawa N
J Clin Pharmacol; 1984; 24(11-12):509-14. PubMed ID: 6511990
[TBL] [Abstract][Full Text] [Related]
55. Steady state pharmacokinetics, metabolism and pharmacodynamics of theophylline in children after unequal twice-daily dosing of a new sustained-release formulation.
Reinhardt D; Berdel D; Heimann G; Kusenbach G; von Berg A; Johnson E; Steinijans VW; Staudinger H
Chronobiol Int; 1987; 4(3):369-80. PubMed ID: 3677217
[TBL] [Abstract][Full Text] [Related]
56. Acute and chronic pharmacokinetics of asymmetrical doses of slow release choline theophyllinate in asthma.
Hibberd SG; Alveyn C; Coombes EJ; Holgate ST
Br J Clin Pharmacol; 1986 Sep; 22(3):337-41. PubMed ID: 3768245
[TBL] [Abstract][Full Text] [Related]
57. Chronopharmacokinetics of theophylline after sustained release and intravenous administration to adults.
Jonkman JH; van der Boon WJ; Balant LP; Schoenmaker R; Holtkamp A
Eur J Clin Pharmacol; 1984; 26(2):215-22. PubMed ID: 6723760
[TBL] [Abstract][Full Text] [Related]
58. Chronotherapy of reversible airways disease with once-daily evening doses of a controlled-release theophylline preparation.
Goldenheim PD; Schein LK
Ann N Y Acad Sci; 1991; 618():490-503. PubMed ID: 2006803
[TBL] [Abstract][Full Text] [Related]
59. Pharmacokinetics of small doses of methotrexate in patients with psoriasis.
Kamel RS; al-Hakiem MH; Rademaker M; Meyrick Thomas RH; Munro DD
Acta Derm Venereol; 1988; 68(3):267-70. PubMed ID: 2455425
[TBL] [Abstract][Full Text] [Related]
60. Comparison of sustained-release theophylline scheduled conventionally (twice-daily, equal interval in equal amount) versus once-daily mornings or evenings on circadian pattern of bronchial patency in asthmatics.
Frankoff HM; Smolensky MH; D'Alonzo GE; Gianotti L; Hsi B; McGovern JP
Chronobiol Int; 1987; 4(3):421-33. PubMed ID: 3315271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
